These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 497633)

  • 1. Pimozide as a neuroleptic.
    Freeman H
    Br J Psychiatry; 1979 Jul; 135():82-3. PubMed ID: 497633
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
    Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
    Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum concentration of depot neuroleptics in tardive dyskinesia.
    Fairbairn AF; Rowell FJ; Hui SM; Hassanyeh F; Robinson AJ; Eccleston D
    Br J Psychiatry; 1983 Jun; 142():579-83. PubMed ID: 6882980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
    Shepherd M
    Prog Neuropsychopharmacol; 1979; 3(4):383-9. PubMed ID: 401349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot injections and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Oct; 133():361-5. PubMed ID: 709010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical uses of pimozide.
    Tueth MJ; Cheong JA
    South Med J; 1993 Mar; 86(3):344-9. PubMed ID: 8451677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia and chronic neuroleptic treatment of Tourette patients.
    Shapiro E; Shapiro AK
    Adv Neurol; 1982; 35():413. PubMed ID: 6959518
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting therapy of schizophrenia.
    Rapisarda V; Bonomo V; Parisi R
    Adv Biochem Psychopharmacol; 1985; 40():25-8. PubMed ID: 4025038
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of pimozide in clinical psychiatry: a review.
    Opler LA; Feinberg SS
    J Clin Psychiatry; 1991 May; 52(5):221-33. PubMed ID: 2033030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum calcium and magnesium levels in chronic schizophrenics.
    Athanassenas G; Papadopoulos E; Kourkoubas A; Tsitourides S; Gabriel J; Hoïdas S; Frangos E
    J Clin Psychopharmacol; 1983 Aug; 3(4):212-6. PubMed ID: 6886033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia [proceedings].
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jan; 13(1):71-3. PubMed ID: 319477
    [No Abstract]   [Full Text] [Related]  

  • 17. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
    Johnson DA
    Br J Psychiatry; 1979 Dec; 135():524-30. PubMed ID: 534806
    [No Abstract]   [Full Text] [Related]  

  • 19. Pimozide in delusions of parasitosis.
    Damiani JT; Flowers FP; Pierce DK
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):312-3. PubMed ID: 2312815
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine.
    Barnes TR; Milavic G; Curson DA; Platt SD
    Soc Psychiatry; 1983; 18(4):193-9. PubMed ID: 6356386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.